Vaishali Pharma (Small Cap - High Growth) Share Target 2026, 2027 To 2035
|
Vaishali Pharma Limited |
|||
|
Price: ₹7.17 (0.42%) | ||
| 52 Week Low: ₹4.75 52 Week High: ₹13.59 |
|||
| Market Capital: 104.76 Crore (Small-cap) | |||
| Healthcare -> Drug Manufacturers - Specialty & Generic | |||
Share Price HistoryVAISHALI FinancialsTomorrow TargetYearly TargetsNo DividendsBonus HistoryNo Split
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Vaishali Pharma Share Price Target For 2026
- 1.1.1: Vaishali Pharma Share Price Target Table For 2026
- 1.1.2: Short-Term Technical Outlook
- 1.2: Vaishali Pharma Share Price Target For 2027
- 1.2.1: Vaishali Pharma Share Price Target Table For 2027
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Vaishali Pharma Share Price Target Chart and Table From 2026, 2027, 2028 to 2035
- 3: Vaishali Pharma Brief Company Overview
- 4: Vaishali Pharma Financial Performance
- 4.0.1: Is Vaishali Pharma A Good Buy For Long Term?
Vaishali Pharma, a Small Cap company in the Drug Manufacturers - Specialty & Generic Industry has delivered 83.1% returns in 5-year showing 38.9% quarterly revenue growth with 7.3% profit margin, making it a High Growth stock.
To predict the Vaishali Pharma's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Vaishali Pharma Share Price Target For 2026
The line chart displays the monthly closing prices of Vaishali Pharma with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Vaishali Pharma shares in 2026, see the table below.
Vaishali Pharma Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 8.29 (+15.62%) | Volatility: ATR T1 |
| 2026 Target 2 | 7.98 (+11.29%) | Trend: Supertrend Resistance |
| 2026 Target 1 | 7.31 (+1.95%) | Volatility: BB Upper |
| Current Price | 7.17 | Vaishali Pharma's share price as of 15 Jun 2026 |
| Stop Loss 1 | 6.89 (-3.91%) | Volatility: BB Lower |
| Stop Loss 2 | 6.05 (-15.63%) | Volatility: ATR S1 |
| Stop Loss 3 | 5.30 (-26.09%) | Volatility: ATR S2 |
Short-Term Technical Outlook
Current Technical Position: Vaishali Pharma is showing mixed momentum signals near key moving averages.
Key Technical Level: The 50-day moving average at ₹7.17 serves as the nearest technical reference point.
Historical Returns: 3-month: +19.7% | 6-month: -10.93% | 1-year: -44.99%
Vaishali Pharma Share Price Target For 2027
The line chart displays the monthly closing prices of Vaishali Pharma with a black line. The green line shows three potential target prices for 2027, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Vaishali Pharma shares in 2027, see the table below.
Vaishali Pharma Share Price Target Table For 2027
| Level | Value | Analysis |
|---|---|---|
| 2027 Target 3 | 8.29 (+15.62%) | Volatility: ATR T1 |
| 2027 Target 2 | 7.98 (+11.29%) | Trend: Supertrend Resistance |
| 2027 Target 1 | 7.31 (+1.95%) | Volatility: BB Upper |
| Current Price | 7.17 | Vaishali Pharma's share price as of 15 Jun 2026 |
| Stop Loss 1 | 6.89 (-3.91%) | Volatility: BB Lower |
| Stop Loss 2 | 6.05 (-15.63%) | Volatility: ATR S1 |
| Stop Loss 3 | 5.30 (-26.09%) | Volatility: ATR S2 |
Long-Term Technical Outlook
52-Week Range Analysis: Vaishali Pharma is currently trading at 27.4% of its 52-week range (₹4.75 - ₹13.59).
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -44.99% | 3-year: -44.04% | 5-year: +83.08%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Vaishali Pharma Share Price Target Chart and Table From 2026, 2027, 2028 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹7.17 | ||
| 2026 | ₹8.82 | +23.012552301255% | ₹8.95 |
| 2027 | ₹11.14 | +26.303854875283% | ₹11.31 |
| 2028 | ₹12.42 | +11.49012567325% | ₹12.61 |
| 2029 | ₹15.24 | +22.705314009662% | ₹15.47 |
| 2030 | ₹17.83 | +16.994750656168% | ₹18.10 |
| 2031 | ₹20.84 | +16.881660123388% | ₹21.15 |
| 2032 | ₹23.65 | +13.483685220729% | ₹24.00 |
| 2033 | ₹27.05 | +14.376321353066% | ₹27.46 |
| 2034 | ₹30.05 | +11.090573012939% | ₹30.50 |
| 2035 | ₹33.48 | +11.414309484193% | ₹33.98 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Vaishali Pharma Brief Company Overview
Vaishali Pharma Limited: Vaishali Pharma Limited, since 1989, is a renowned pharmaceutical company based in Mumbai, India. The company focuses on manufacturing and distributing a diverse range of pharmaceutical products in India and internationally. ...
Key Products and Services: Active Pharmaceutical Ingredients (APIs) Formulation Products (e.g., laxatives, vitamins) Excipients and Enzymes Veterinary Pharmaceuticals Nutraceuticals Herbal and Surgical Products Vaishali Pharma Limited is committed to providing high-quality and affordable healthcare solutions to its customers.Vaishali Pharma Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 163.36 Crore | Market valuation of Vaishali Pharma's shares. |
| Revenue (TTM) | 80.12 Crore | Total revenue generated by Vaishali Pharma over the past twelve months. |
| Net Income (TTM) | +5.83 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 10.14% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 7.28% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+38.9% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
-20.7% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
33.98 | Company's total debt divided by total shareholder equity. |
| Total Debt | 15.04 Crore | Sum of Vaishali Pharma's current & long-term financial obligations. |
| Total Cash | 42.6 Lakh | Total amount of liquid funds available to Vaishali Pharma. |
| Beta | 0.41 | Beta is less than 1 indicating that the Vaishali Pharma's price is less volatile than the market. |
Is Vaishali Pharma A Good Buy For Long Term?
While Vaishali Pharma has experienced a revenue increase, its earnings have declined by 20.7% compared to the same quarter last year. Notably, the company has a low profit margin of 7.28% and a debt of 15.04 Crore declared in their Q3-2023-24 Quarterly Report. Given these factors, Vaishali Pharma may not be a strong choice for long-term investment.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
